Skip to content

Celcuity CELC Accrued Expenses

Accrued Expenses at other companies

Eli Lilly logo
Eli LillyLLY
$1.36B+22.0%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$39.34M+17.6%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$847K-49.6%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$3.24M+1.9%
CG Oncology logo
CG OncologyCGON
$25.91M+65.5%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
$13.11M

Other financials

Income statement

See full
Operating income-$50.5M-39.8%
Net income-$52.8M-42.8%
EPS (diluted)-$0.97-12.8%

Balance sheet

See full
Cash & equivalents$145.2M+781%
Total debt$137.9M+30.7%
Total equity$53.5M-38.2%
Total assets$410.2M+88.0%

Cash flow

See full
Operating cash flow-$55.1M-53.6%
CapEx$249.0K+315%
Free cash flow-$55.3M-54.0%

Valuation

See full
Market cap$4.4B+1,370%

Returns & leverage

See full
Return on equity-275.2%-990pp
Debt / equity2.6×+1.4×
Current ratio12.3×+5.7×

Where this comes from

Reported directly by Celcuity in its filing.

Tagged under the XBRL concept us-gaap:OtherAccruedLiabilitiesCurrentAndNoncurrent.

The official record: Celcuity’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celcuity's accrued expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Celcuity's accrued expenses?
Celcuity (CELC) reported accrued expenses of $1.25M in Q1 2026.
How has Celcuity's accrued expenses changed year-over-year?
Celcuity's accrued expenses decreased by 94.5% year-over-year, from $22.82M to $1.25M.
What is the long-term trend for Celcuity's accrued expenses?
Over 5 years (2020 to 2025), Celcuity's accrued expenses has grown at a 34.1% compound annual growth rate (CAGR), from $137.02K to $595K.
What does accrued expenses mean?
Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.